Strs Ohio Sells 35,100 Shares of Alignment Healthcare, Inc. $ALHC

Strs Ohio trimmed its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 71.5% in the third quarter, Holdings Channel reports. The institutional investor owned 14,000 shares of the company’s stock after selling 35,100 shares during the period. Strs Ohio’s holdings in Alignment Healthcare were worth $244,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Invesco Ltd. raised its stake in shares of Alignment Healthcare by 122.3% during the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after acquiring an additional 2,294,739 shares during the last quarter. Marshall Wace LLP increased its holdings in Alignment Healthcare by 173.3% in the second quarter. Marshall Wace LLP now owns 2,039,714 shares of the company’s stock valued at $28,556,000 after purchasing an additional 1,293,416 shares during the period. Voya Investment Management LLC raised its position in Alignment Healthcare by 61.0% during the 3rd quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company’s stock worth $55,775,000 after purchasing an additional 1,210,930 shares during the last quarter. Qube Research & Technologies Ltd lifted its holdings in Alignment Healthcare by 269.6% during the 2nd quarter. Qube Research & Technologies Ltd now owns 1,523,986 shares of the company’s stock worth $21,336,000 after buying an additional 1,111,685 shares during the period. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Alignment Healthcare in the 2nd quarter valued at about $10,483,000. Institutional investors own 86.19% of the company’s stock.

Insider Activity

In other news, insider Robert L. Scavo sold 69,541 shares of the firm’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the transaction, the insider directly owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. This trade represents a 12.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Dawn Christine Maroney sold 282,070 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80. Following the completion of the sale, the president owned 1,385,167 shares of the company’s stock, valued at $25,958,029.58. The trade was a 16.92% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 2,103,532 shares of company stock worth $40,529,538. 6.60% of the stock is currently owned by insiders.

Alignment Healthcare Price Performance

ALHC stock opened at $22.65 on Tuesday. The firm has a 50 day moving average of $20.59 and a 200-day moving average of $17.57. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The firm has a market capitalization of $4.53 billion, a P/E ratio of -188.75, a price-to-earnings-growth ratio of 5.93 and a beta of 1.16.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ALHC shares. UBS Group boosted their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 14th. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, January 17th. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. Finally, TD Cowen increased their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Alignment Healthcare has an average rating of “Moderate Buy” and an average target price of $23.05.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.